Stay updated on Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.

Latest updates to the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew revision entry added: Revision: v3.6.4, and Revision: v3.6.3 removed from the record history. This update changes only the version history on the page and does not affect trial data or content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check37 days agoChange DetectedThe record history shows the site revision updated from v3.6.2 to v3.6.3, indicating a minor interface update.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry (v3.6.2) was added to the record history, and the previous revision (v3.6.0) was removed. This update reflects a maintenance change to the page's version history rather than a modification to the study content.SummaryDifference0.1%

- Check58 days agoChange DetectedNew quick-access links 'Check who can join' and 'Find Contact Information' appear on the record history page to facilitate access to eligibility details and contact information for the study. The revision history now shows version 3.6.0 and removes the previous 3.5.5 entry, indicating an updated record.SummaryDifference0.6%

- Check65 days agoChange DetectedA new revision entry 'Revision: v3.5.5' is added to the record history. The previous 'Revision: v3.5.4' entry is removed, updating the displayed version history.SummaryDifference0.1%

- Check86 days agoChange DetectedA new revision entry v3.5.4 was added to the history. The previous entry v3.5.3 was removed, updating the page’s revision trail.SummaryDifference0.1%

Stay in the know with updates to Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.